Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
Close
  • Menu
  • Setting

BI-9564

Catalog No.
B6184
BRD9/7 specific inhibitor
Grouped product items
Size Price Stock Qty
2mg
Special Price $27.00 Regular Price $60.00
In stock
5mg
Special Price $37.35 Regular Price $83.00
In stock
10mg
Special Price $65.25 Regular Price $145.00
In stock
50mg
Special Price $256.50 Regular Price $570.00
In stock
100mg
Special Price $389.25 Regular Price $865.00
In stock
200mg
Special Price $715.50 Regular Price $1,590.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

No Related Posts

Background

IC50: 75 nM and 3.4 μM for BRD9 and BRD7 bromodomains, respectively

BI-9564 is a BRD9/7 specific inhibitor.

BRD7 and BRD9 are two important members of the bromodomain family protein. Both BRD7 and BRD9 have been implicated in chromatin remodeling.

In vitro: BI-9564 was identified as a BRD9/7 specific inhibitor via fragment-based screening and structure-guided design. BI-9564 was found to be bind to BRD9 with a higher affinity than to BRD7, and was negative on BET family proteins. In addition, BI-9564 demonstrated in vitro off-target selectivity to CECR2, but not in cells [1].

In vivo: In animal study, BomTac:NMRIFoxn1nu mice were given two oral doses daily and the concentration of BI-9564 in plasma was measured. Dose-dependent AUCs were obtained for BI-9564, achieving exposures that were higher compared to the EC50 level for EOL-1 cells. Moreover, when the oral treatment with BI-9564 at 180 mg/kg was initiated on day 5 and applied daily with an interruption at day 18 and 19, a significant reduction in tumour growth compared to controls was found on day 18 leading to a median tumour growth inhibition value of 52% [1].

Clinical trial: Up to now, BI-9564 is still in the preclinical development stage.

Reference:
[1] Martin LJ et al.  Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor. J Med Chem. 2016 May 26;59(10):4462-75.

Chemical Properties

Physical AppearanceA crystalline solid
StorageStore at -20°C
M.Wt353.41
Cas No.1883429-22-8
FormulaC20H23N3O3
Solubility≥8.82 mg/mL in DMSO with ultrasonic,≥8.32 mg/mL in EtOH with ultrasonic,insoluble in H2O
Chemical Name4-(4-((dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one
SDFDownload SDF
Canonical SMILESO=C1N(C)C=C(C2=CC(OC)=C(CN(C)C)C=C2OC)C3=CC=NC=C13
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control